Biosecurity

DARPA invests $100 million in gene-altering technology

By Elisabeth Eaves | Biosecurity, What We’re Reading

Antimicrobial resistance: an underrated biological threat

By Saskia Popescu | Biosecurity, Voices of Tomorrow

From Justin Bieber to genotypes

By Lucien Crowder | Biosecurity, Disruptive Technologies, Synthetic biology, What We’re Reading

What should the US national biodefense strategy look like?

By Laura H. Kahn | Biosecurity, Columnists

Introduction: The Trump administration’s approach to existential threat

By John Mecklin | Biosecurity, Climate Change, Disruptive Technologies, Nuclear Weapons, Technology and Security

The Trump’s administration’s misaligned approach to national biodefense

By Reid Kirby | Biosecurity

We’ve got to talk: The militarization of biotechnology

By Brett Edwards | Analysis, Biosecurity

Better babies through Crispr

By Lucien Crowder | Biosecurity, Disruptive Technologies, Synthetic biology, Technology and Security, What We’re Reading

Gene-drive research: DARPA lays its bets

By Lucien Crowder | Biosecurity, What We’re Reading

North-Korean-map-chemical-weapons.jpg

Potemkin or real? North Korea’s biological weapons program

By Sonia Ben Ouagrham-Gormley | Analysis, Biosecurity

Ignore Bill Gates: Where bioweapons focus really belongs

By Filippa Lentzos | Analysis, Biosecurity

Why access to health care is a national security issue

By Laura H. Kahn | Biosecurity, Columnists